, Tracking Stock Market Picks
Enter Symbol:
Rating: NSPR
Buy $4

INSPIREMD INC (AMEX: NSPR) rated to Buy with price target $4 by Rodman & Renshaw

Thursday,  Jan 7, 2016  8:25 AM ET by Lynn Gilbert

Rodman & Renshaw rated
INSPIREMD INC (AMEX: NSPR) to Buy with price target $4.

InspireMD, Inc. is a medical device company focusing on the development and commercialization of its proprietary stent platform technology, MGuard. MGuard provides embolic protection in stenting procedures by placing a micron mesh sleeve over a stent. The Company?s initial products are marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The Company markets its products through distributers in international markets, mainly in Europe and Latin America.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy